Araz Jakalian - Concepedia

Author

Araz Jakalian

Boehringer Ingelheim (Canada)

Also Known As

A. Jakalian, Araz Jakalian

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Canada)Boehringer Ingelheim (Germany)Boehringer Ingelheim (Egypt)Concordia University Merck Canada Inc. (Canada)

About

Araz Jakalian is an author at Boehringer Ingelheim (Canada) specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.4K
2	Natural Sciences	18	19	5.8K
3	Biochemistry	13	13	1.1K
4	Engineering	6	6	5.6K
5	Applied Physics	4	4	5.1K

Araz Jakalian

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation Araz Jakalian, D. B. Jack, Christopher I. Bayly Journal of Computational Chemistry EngineeringComputational ChemistryChemistryCharge TransportCharge Model	2002	3.4K
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method Araz Jakalian, Bruce L. Bush, D. B. Jack, Journal of Computational Chemistry Am1-bcc MethodEngineeringOrganometallic ElectrochemistryComputational ChemistryChemistry	2000	1.6K
Revealing Atropisomer Axial Chirality in Drug Discovery Steven R. LaPlante, Paul Edwards, Lee D. Fader, ChemMedChem Molecular PharmacologyMedicinal ChemistryMolecular SciencesEngineeringBiochemistry	2011	499
Solvated Interaction Energy (SIE) for Scoring Protein−Ligand Binding Affinities. 1. Exploring the Parameter Space Marwen Naïm, Sathesh Bhat, Kathryn N. Rankin, Journal of Chemical Information and Modeling	2007	419
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1 Lee D. Fader, Éric Malenfant, Mathieu Parisien, ACS Medicinal Chemistry Letters Hiv-1 IntegraseImmunologyMolecular BiologyPharmacotherapyBi 224436	2014	175
An Analysis of the Interactions between the Sem−5 SH3 Domain and Its Ligands Using Molecular Dynamics, Free Energy Calculations, and Sequence Analysis Wei Wang, Wendell A. Lim, Araz Jakalian, Journal of the American Chemical Society	2001	133
Unique Thermodynamic Response of Tipranavir to Human Immunodeficiency Virus Type 1 Protease Drug Resistance Mutations Salman Muzammil, Anthony A. Armstrong, Lin‐Woo Kang, Journal of Virology MedicineHuman RetrovirusPathogenesisImmunologyAntiviral Therapy	2007	123
Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor Craig Fenwick, Ma’an Amad, Murray D. Bailey, Antimicrobial Agents and Chemotherapy	2014	98
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method Araz Jakalian, Bruce L. Bush, D. B. Jack, Journal of Computational Chemistry Am1-bcc MethodEngineeringOrganometallic ElectrochemistryComputational ChemistryChemistry	2000	96
Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: From benzimidazole to indole scaffolds Pierre L. Beaulieu, James Gillard, Darren Bykowski, Bioorganic & Medicinal Chemistry Letters Hcv Ns5b PolymeraseBiochemistryReplicon Cellular ActivityNatural SciencesAntiviral Drug Development	2006	81

Page 1